CD Biosynsis provides specialized Pichia pastoris Multi-Gene Knockout Strain Construction Services, offering precise and permanent deletion of multiple target genes in this high-performance protein expression host. Pichia pastoris (Komagataella phaffii) is recognized as the industry standard for high-density fermentation and massive secretion of heterologous proteins. Multi-gene knockout is a critical step in advanced strain engineering, primarily used to eliminate redundant metabolic pathways, remove multiple product-degrading proteases, or fully disrupt native glycosylation pathways. Leveraging the host's high efficiency of Homology-Directed Repair (HDR) coupled with the precision of multiplex CRISPR-Cas9, we ensure clean, stable, and markerless deletions (typically 2 to 10 genes) to create next-generation Pichia pastoris chassis strains for optimal biomanufacturing.
Get a QuoteAchieving multiple sequential gene knockouts in yeast is traditionally time-consuming. Our platform accelerates this by employing optimized multiplex CRISPR-Cas9 systems that leverage the intrinsic high efficiency of the Pichia pastoris Homology-Directed Repair (HDR) pathway. This allows us to perform several clean gene deletions (KO) in a single transformation or rapidly execute sequential deletions using marker recycling. This capability is critical for creating advanced strains with dismantled competing pathways, enhanced folding capacity, and simplified glycan profiles, resulting in a robust, genetically defined chassis ready for large-scale industrial protein production.
gRNA Cascade Design
Rational design of multiple guide RNAs (gRNAs) simultaneously targeting 2 to 10 genes, enabling single-step knockout of several pathways using one transformation in Pichia pastoris.
Multiplex Repair Template
Design of short DNA repair donors linked to selection markers or recycling systems, ensuring simultaneous and clean deletion of multiple loci via the Pichia HDR pathway.
Sequential vs. Simultaneous
Strategy optimization based on target function; performing simultaneous knockouts for non-essential genes or sequential editing (using marker recycling) for essential/toxic gene deletions.
NLS-Cas9 and gRNA Expression
Use of Cas9 equipped with a Nuclear Localization Signal (NLS) to ensure successful editing complex delivery and activity within the Pichia pastoris nucleus.
Marker Recycling Systems
Implementation of marker recycling (e.g., Cre-LoxP or auxotrophic restoration) to allow for multiple, sequential editing rounds without accumulating antibiotic resistance cassettes.
Eukaryotic Transformation
Optimized transformation methods (e.g., electroporation) tailored for high-efficiency uptake of Cas9 and large multiplexed donor DNA fragments by Pichia pastoris.
Protease System Disruption
Deletion of multiple secreted and vacuolar protease genes (e.g., PEP4, PRB1, KEX1) to prevent product degradation and ensure high yield of intact protein.
Glycosylation Pathway Knockouts
Systematic deletion of native glycan-modifying enzymes to simplify the host's glycosylation profile, necessary for subsequent humanized glycoengineering.
Metabolic Byproduct Elimination
Strategic deletion of redundant genes in competing metabolic pathways (e.g., glycerol synthesis) to fully redirect carbon flux toward the target product.
A systematic process for construction, verification, and stabilization of multi-knockout strains.
1. Rational Target Selection
2. Multiplex System Construction
3. Eukaryotic Transformation and Selection
4. Verification and Stabilization
Identify all native genes (2+) that need to be deleted based on degradation profile or metabolic modeling.
Design multiplex gRNA cascade and non-coding homology repair templates for clean deletion via HDR.
Determine the optimal strategy: single-step multiplexing or sequential editing using marker recycling.
Assemble the polycistronic gRNA expression cassette and NLS-Cas9 delivery vector.
Clone the repair template(s) into the appropriate delivery vehicle for homologous recombination.
Verify the integrity of the constructed multi-gene editing plasmids.
Genotype verification via multiplex PCR and definitive Sanger sequencing of all target loci to confirm clean deletions.
Validate the resulting phenotype (e.g., reduced protease activity, simplified glycan) and genetic stability.
Delivery of the verified, markerless Pichia pastoris multi-knockout strain.
High Multiplexing HDR
Optimized CRISPR systems achieve high editing rates, facilitating the simultaneous deletion of multiple genes in a single step via the robust Pichia pastoris HDR pathway.
Targeted Quality Control
Expertise in eliminating key protease and glycosylation genes, a crucial step for maximizing the purity and stability of high-value therapeutic and secreted proteins.
Clean and Markerless
Protocols integrate selection marker recycling, ensuring the final strains are free of residual foreign DNA, maintaining a clean background for industrial and regulatory use.
Eukaryotic Targeting
Specialized NLS-Cas9 systems ensure efficient delivery of the editing complex to the Pichia pastoris nucleus, overcoming the compartmentalization barrier.
1. Why is Pichia pastoris suitable for multi-gene knockout?
The primary advantage is its highly active Homology-Directed Repair (HDR) pathway, which is leveraged by multiplex CRISPR-Cas9 to perform multiple clean, precise gene deletions efficiently and stably.
2. What is the role of the Nuclear Localization Signal (NLS) in the Cas9 system?
As a eukaryotic cell, Pichia pastoris sequesters its DNA in the nucleus. The NLS tag is essential for transporting the Cas9 enzyme into the nucleus so it can access and cleave the genomic DNA at the target loci.
3. How do you ensure the final strain is markerless after multiplex editing?
We use marker recycling systems (e.g., based on the Cre-LoxP system or counter-selection) that allow the temporary selection cassette to be excised or cured, leaving a clean, edited genome for industrial use.
4. What types of genes are commonly deleted in a multi-knockout project?
Common targets include native proteases (e.g., KEX1, PEP4), genes in the high-mannose glycosylation pathway (e.g., OCH1), and enzymes in metabolic shunts (e.g., glycerol synthesis).
5. How do you confirm the deletion of all target genes in a single strain?
We use robust genotype verification, typically multiplex PCR (to check the genomic rearrangement size at all loci simultaneously), followed by definitive Sanger sequencing of each edited region to confirm clean, precise deletions.
6. Can the multi-gene knockout be performed in industrial polyploid strains?
Yes. Our protocols are optimized for industrial polyploid strains. We use specialized quantitative PCR (qPCR) methods to confirm the deletion of all homologous alleles across the genome.
7. What is the role of the donor template in the knockout process?
The donor template (or repair template) contains short flanking sequences that guide the Pichia HDR machinery to precisely remove the target gene sequence, replacing it with a small, inert DNA scar or a selection marker that is later removed.
8. What initial input is required from the client for this service?
The client needs to provide the gene names or locus tags of the genes (2 or more) to be knocked out and the specific Pichia pastoris host strain (or wild-type strain) to be used for the modification.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.